alexa Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells.
Neurology

Neurology

International Journal of Neurorehabilitation

Author(s): Skladanowski A, Konopa J

Abstract Share this page

Abstract HeLa S3 cells exposed to Adriamycin and Daunomycin for 3 hr at EC90 and 10 x EC90 concentrations and incubated in drug-free medium demonstrated the characteristics of apoptosis, morphological changes and fragmentation of DNA into oligonucleosome-sized fragments. The kinetics of DNA degradation after incubation with Adriamycin did not differ significantly at the EC90 and 10 x EC90 concentrations and DNA fragmentation in cells treated with both doses of Adriamycin could be observed after 12 hr of post-incubation in drug-free medium. At the EC90 concentration of Daunomycin, DNA fragmentation was not observed until 24 hr after drug exposure, whereas at the 10 x EC90 concentration apoptosis-related DNA degradation was detectable as early as 3 hr after drug treatment. For both drugs, at both studied concentrations, HeLa S3 cells were arrested in the G2 phase of the cell cycle as can be concluded from cell size distribution studies. Additionally, the growth inhibition of HeLa S3 cells treated with the drugs was observed at concentrations about 10 times lower than those inhibiting DNA synthesis of these cells. At lower concentrations of Adriamycin and Daunomycin (EC90), apoptosis was inhibited by post-incubation with 1 microgram/mL cycloheximide whereas at higher concentrations of the drugs (10 x EC90) there was a potentiation of cell death in cycloheximide-treated cells. The presented results suggest that apoptosis may be the process directly responsible for cell killing by Adriamycin, Daunomycin and probably other anthracyclines, in which the cytostatic effect of these compounds leads to cytotoxicity (cell death).
This article was published in Biochem Pharmacol and referenced in International Journal of Neurorehabilitation

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

gene[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords